PE20080347A1 - Solucion oftalmica de ciprofloxacina y dexametasona - Google Patents
Solucion oftalmica de ciprofloxacina y dexametasonaInfo
- Publication number
- PE20080347A1 PE20080347A1 PE2007000833A PE2007000833A PE20080347A1 PE 20080347 A1 PE20080347 A1 PE 20080347A1 PE 2007000833 A PE2007000833 A PE 2007000833A PE 2007000833 A PE2007000833 A PE 2007000833A PE 20080347 A1 PE20080347 A1 PE 20080347A1
- Authority
- PE
- Peru
- Prior art keywords
- dexametasone
- cyprofloxacin
- ophthalmic solution
- approximately
- sodium
- Prior art date
Links
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 title abstract 2
- 229940054534 ophthalmic solution Drugs 0.000 title 1
- 239000002997 ophthalmic solution Substances 0.000 title 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 1
- DIOIOSKKIYDRIQ-UHFFFAOYSA-N ciprofloxacin hydrochloride Chemical compound Cl.C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 DIOIOSKKIYDRIQ-UHFFFAOYSA-N 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 229940037001 sodium edetate Drugs 0.000 abstract 1
- 229910052938 sodium sulfate Inorganic materials 0.000 abstract 1
- 235000011152 sodium sulphate Nutrition 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2006/000062 WO2008002117A1 (fr) | 2006-06-27 | 2006-06-27 | Solution ophtalmique de ciprofloxacine et de dexaméthasone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080347A1 true PE20080347A1 (es) | 2008-04-11 |
Family
ID=38845821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000833A PE20080347A1 (es) | 2006-06-27 | 2007-06-27 | Solucion oftalmica de ciprofloxacina y dexametasona |
Country Status (3)
| Country | Link |
|---|---|
| CL (1) | CL2007001894A1 (fr) |
| PE (1) | PE20080347A1 (fr) |
| WO (1) | WO2008002117A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107970244B (zh) * | 2016-10-21 | 2020-07-14 | 武汉武药科技有限公司 | 一种含有环丙沙星和地塞米松的组合物及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6740664B2 (en) * | 1998-09-30 | 2004-05-25 | Alcon, Inc. | Methods for treating otic and ophthalmic infections |
| BR0115415A (pt) * | 2000-11-15 | 2003-09-09 | Mohan A Chandavarkar | Droga de combinação |
| WO2004069280A1 (fr) * | 2003-02-06 | 2004-08-19 | Cipla Ltd | Complexes d'inclusion pharmaceutiques contenant un steroide et un agent antibacterien facultatif |
| WO2004087043A2 (fr) * | 2003-02-21 | 2004-10-14 | Sun Pharmaceutical Industries Limited | Composition ophtalmique stable |
-
2006
- 2006-06-27 WO PCT/MX2006/000062 patent/WO2008002117A1/fr not_active Ceased
-
2007
- 2007-06-27 CL CL2007001894A patent/CL2007001894A1/es unknown
- 2007-06-27 PE PE2007000833A patent/PE20080347A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008002117A1 (fr) | 2008-01-03 |
| CL2007001894A1 (es) | 2008-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014019667A2 (pt) | formulação de anticorpo abeta | |
| BR112012008518A2 (pt) | derivado heterocíclico, e, composição farmacêutica | |
| ME01456B (me) | Fumaratna so (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola | |
| PE20130009A1 (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana | |
| PE20141070A1 (es) | Composiciones estables de povidona yodada con antiinflamatorios esteroideos o no esteroideos | |
| EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
| PE20121498A1 (es) | Composiciones oftalmicas no irritantes de povidona-yodo | |
| BRPI0518301A2 (pt) | inseticidas | |
| IN2012DN02465A (fr) | ||
| NO20084853L (no) | Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni | |
| AU2012243329A8 (en) | 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use | |
| CL2008001839A1 (es) | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. | |
| CO6541569A2 (es) | Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa | |
| BR112013005438A2 (pt) | "agente para o tratamento de olho ressecado caracterizado por combinar o agonista do receptor de p2y2 e ácido hialurônico ou um sal do mesmo, método para o tratamento de olho ressecado, e uso do agonista do receptor de p2y2, e ácido hialurônico ou um sal do mesmo." | |
| PE20081752A1 (es) | Sal de napadisilato de 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2-(1h)-ona como agonista del receptor adrenergico b2 | |
| PE20130217A1 (es) | Composiciones farmaceuticas y metodos para su elaboracion | |
| BR112013011580A2 (pt) | derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep | |
| PA8759501A1 (es) | Formas cristalinas | |
| MX2010007295A (es) | Composiciones acuosas estables de ciclosporina. | |
| PE20080053A1 (es) | Composiciones oftalmicas de alcaftadina | |
| PE20081751A1 (es) | Composicion farmaceutica que comprende un antagonista muscarinico y antagonista beta-2 adrenorreceptor | |
| PE20091392A1 (es) | Composiciones farmaceuticas como agentes antiinflamatorios | |
| PE20120648A1 (es) | Compuestos de 4-isopropilfenilglucitol como inhibidores de sglt1 | |
| RU2012103538A (ru) | Композиции и способы ингибирования пути jak | |
| BR112013022094A2 (pt) | composições e métodos para o tratamento não cirúrgico da ptose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FX | Voluntary withdrawal |